Table 6 Ratio between 21-d RES (MAF × 21d-fTWA) for a simulation of 2 applications with 10 day interval with TREC using the DT50 from SFO3 and 21-d RES from the respective best fit model
| Â | # best fit is SFO7 (all data) | Ratio of SFO3 21-d RES/best fit 21-d RES | ||
|---|---|---|---|---|
Mean over 6 trials | Min over 6 trials | Max over 6 trials | ||
Fluopyram | 6 | 1.16 | 1.01 | 1.30 |
Trifloxystrobin | 3 | 0.98 | 0.81 | 1.10 |
Spiroxamine | 1 | 1.01 | 0.83 | 1.14 |
Fluopicolide | 1 | 0.97 | 0.83 | 1.05 |
Tebuconazole | 1 | 0.92 | 0.73 | 1.09 |
Propineb | 1 | 1.02 | 0.73 | 1.36 |